Rosetta Genomics Ltd.'s Recent Study Demonstrating the Ability of miRview(TM) squamous to Reliably Classify Non Small Cell Lung Cancer, to Be Presented at the 2nd European Lung Conference in Geneva, Switzerland

REHOVOT, Israel & PHILADELPHIA--(BUSINESS WIRE)--Rosetta Genomics, Ltd. (NASDAQ:ROSG), a leading developer and provider of microRNA-based molecular diagnostic tests, announced today that Dr. William Westra, Professor of Pathology, Oncology, and Otolaryngology/Head & Neck Surgery at The Johns Hopkins Medical Institutions, who led the study, will give an oral presentation at the upcoming European Lung Conference in Geneva, Switzerland.